JPRN-jRCT2031210566已完成2 期
Follow ups of patients in AK1830 Phase II Studies
Kudo Katsuyasu0 个研究点目标入组 10 人开始时间: 2022年1月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who provided written informed consent to participate in the clinical study and who met all of the following criteria
- •[1] Patients who participated in the AK1830 Phase II Study and were deemed to require follow up.
- •[2] Patients who fully understand the contents of the study and are capable of providing informed consent
排除标准
- •Patients who met any of the following criteria are to be excluded.
- •[1] Patients who have received their long-term safety outcomes in the AK1830 Phase II Study
- •[2] Patients deemed by the investigator or sub-investigator to be unsuitable for study participation
研究者
相似试验
未知
2 期
K012 phase II clinical studyColorectal cancerJPRN-jRCT2080220752ippon Kayaku Co., Ltd.
已完成
2 期
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.JPRN-jRCT2080224985Asahi Kasei Pharma Corporation400
尚未招募
2 期
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.Pain due to osteoarthritisJPRN-jRCT2031230469Kudo Katsuyasu400
已完成
2 期
Randomized, Double-Blind Study of AK1830 in Patients with low back paiow back painJPRN-jRCT2080225352Asahi Kasei Pharma Corporation400
尚未招募
2 期
STUDY ON AKKARAM(STOMATITIS)WITH EVALUATION OF SIDDHA DRUGAKKARAM ENNAICTRI/2021/01/030644Government siddha medical college